Biotech/Biomedical
News Category

Regentis Biomaterials Advances GelrinC Toward Regulatory Approval and Commercial Expansion
Regentis Biomaterials is progressing its GelrinC cartilage regeneration implant through clinical trials, FDA submission preparation, and European comm...

Quantum BioPharma's Dual Strategy Targets Neurological Health with Lucid-MS and unbuzzd
Quantum BioPharma advances a two-pronged approach to neurological health, combining its investigational MS therapy Lucid-MS with its supplement unbuzz...

Quantum BioPharma Advances Dual Strategy for Neurological Health with MS Therapy and Alcohol Supplement
Quantum BioPharma is advancing a two-pronged approach to neurological health, targeting myelin repair in multiple sclerosis with Lucid-MS and addressi...

VERAXA Biotech Builds Strategic Position in Antibody Therapeutics Market
VERAXA Biotech's proprietary BiTAC platform and pipeline of next-generation antibody therapeutics position it for potential partnerships and licensing...

Kevin Stitt Joins Veetee USA to Drive Walmart and Publix Expansion
Veetee USA appoints CPG veteran Kevin Stitt to lead retail expansion at Walmart and Publix, leveraging its unique steam cooking process and upcoming S...

Lantern Pharma Schedules Q2 2026 Results Webcast, Highlighting AI-Driven Oncology Progress
Lantern Pharma's upcoming webcast signals continued momentum in its AI-driven oncology pipeline and commercial AI platform, underscoring its strategic...

Earth Science Tech Reports 57% Increase in Fiscal First-Quarter Net Income
Earth Science Tech's fiscal Q1 2027 results show a 57% net income surge, signaling strong operational performance and strategic growth.

Thorium Atomics Begins Pre-Application Regulatory Engagement with U.S. NRC for Tesseract TGR Advanced Reactor
Thorium Atomics has initiated pre-application engagement with the U.S. Nuclear Regulatory Commission for its Tesseract TGR advanced reactor, marking a...

VERAXA Advances VXA-222 Cancer Program and Expands Patent Portfolio
VERAXA Biotech has advanced its VXA-222 bispecific ADC program past the discovery phase and expanded its patent portfolio, underscoring its progress i...

American Fusion Expands Patent Portfolio and Advances Texatron Development
American Fusion Inc. files six new patent applications, reaching 82 total, and progresses toward OTCQB listing and next-phase testing, underscoring it...

Nano-X Imaging Announces $8 Million Registered Direct Offering to Fund Preventive Healthcare Platform Expansion
Nano-X Imaging's $8 million registered direct offering underscores its commitment to advancing affordable medical imaging and preventive healthcare, w...

New Liquid Biopsy Predicts Immunotherapy Response in Advanced Lung Cancer
A novel liquid biopsy offers a simpler method to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving trea...

GeoVax Completes Key GEO-MVA Milestones, Paving Way for Pivotal Phase 3 Study
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA mpox/smallpox vaccine, positioning it f...

Innovative Designs Reports Best Fiscal Q3 in Company History with Nearly 40% Revenue Growth and Eighth Consecutive Profitable Quarter
Innovative Designs, Inc. announces record fiscal third-quarter revenues, marking its eighth straight profitable quarter, and advances its Insultex Hou...

July Wellness Index Report: A Shift Toward Working with the Body's Own Biology
The July Wellness Index Report highlights a growing trend in longevity medicine that prioritizes supporting the body's natural processes over overridi...

Regentis Advances GelrinC: European Approval Boosts Production Yield by 400%, Positioning It as a Cost-Effective Standard of Care for Knee Cartilage Repair
Regentis Biomaterials' European approval of a next-generation manufacturing process for GelrinC enhances production yield by 400%, reducing costs and ...

Purple Exhibits Streamlines KBIS 2027 with Turnkey Services and Expert Oversight
Purple Exhibits announces comprehensive turnkey services for KBIS 2027, led by Key Account Manager Joey Bartman, ensuring exhibitors benefit from spec...

Onco-Innovations Integrates Targeted Cancer Therapy, Nanotechnology, and AI to Advance Oncology Drug Development
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and causal AI to accelerate cancer drug development, with lead cand...

Earth Science Tech's Integrated Telehealth Platform Positions It for Growth in the Digital Health Market
Earth Science Tech's strategic focus on vertical integration and proprietary technology in telehealth and peptide therapy underscores its potential to...

Big Tech Earnings Whiplash, KOSPI Wipeout, and a SpaceX Rug Pull: DH Unplugged Episode 812 Dissects Market Chaos
Episode 812 of DH Unplugged analyzes the volatile market reactions to Big Tech earnings, the KOSPI crash, and SpaceX's post-IPO decline, highlighting ...

Ancient Immune Protein C3 Found to Enhance Immunotherapy Effectiveness Against Tumors
Nagoya University researchers discovered that the immune protein C3, when produced within tumors, can make them more susceptible to immunotherapy, pot...

American Fusion Showcases Texatron Development at Major Physics Conference
American Fusion's CTO presented the Texatron Fusion Engine program and GEM Unification Theory at the APS DPF 2026 Meeting, boosting the company's visi...

VolitionRx Publishes Peer-Reviewed Study on Capture-Seq Liquid Biopsy Technology
VolitionRx's new Capture-Seq technology achieves >99% pure ctDNA isolation, potentially transforming cancer detection and monitoring, with a combined ...

Tonix Pharmaceuticals to Present at Major Investor Conferences in August and September
Tonix Pharmaceuticals announced its participation in two key investor conferences, highlighting its ongoing efforts to engage with the investment comm...

VERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, strength...

LataMed AI to Discuss AI in Healthcare and Systems Engineering at Universidad Santa Maria
LataMed AI Corp. will present at a university conference in Venezuela, highlighting the role of AI in healthcare and systems engineering, which unders...

NeuroThera Labs Expands Phase IIb Trial of SCI-110 for Tourette Syndrome to Yale Child Study Center
NeuroThera Labs has initiated its Phase IIb clinical trial at Yale Child Study Center, advancing a potential new cannabinoid-based treatment for Toure...

Medios Appoints Katrin Neuffer to Lead Investor Relations and Communications
Medios AG has appointed Katrin Neuffer as Director Investor Relations & Communications, bringing her extensive capital markets experience to guide the...

SRX Global Acquires Stake in Vistagen Therapeutics, Signaling Confidence in Neuroscience Pipeline
SRX Global's investment in Vistagen Therapeutics underscores its strategy to unlock value in undervalued biopharmaceutical assets, potentially influen...

SRX Global Acquires Stake in Vistagen Therapeutics, Seeing Undervaluation
SRX Global's acquisition of a stake in Vistagen highlights its strategy of investing in undervalued high-conviction companies and engaging with manage...

Measles Outbreak Reaches 30-Year High in US, Prompting Renewed Focus on Vaccination and Contact Tracing
The US surpasses its 2025 measles case total, reaching a 30-year high, highlighting the urgent need for robust contact tracing and vaccination efforts...

TreVita Launches Hair Transplant Services in Mexico, Expanding Premium Medical Travel Platform
TreVita's new hair transplant offering in Zona Rio, Mexico, expands its medical travel services, addressing growing demand for affordable, high-qualit...

San Francisco Dental Implant Center Highlights All-on-4 Implants for Local Residents
San Francisco Dental Implant Center releases new content on All-on-4 implants, emphasizing their benefits and the importance of consultation for eligi...

Regentis Biomaterials Advances GelrinC, a Potential First-in-Class Cartilage Regeneration Platform, Addressing Major Unmet Need
Regentis Biomaterials is advancing GelrinC, a cell-free, off-the-shelf hydrogel for cartilage repair, targeting a market of 470,000 annual U.S. cases ...

Quantum BioPharma's MS Imaging Study Shows Encouraging Preliminary Results at Enrollment Midpoint
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached its enrollment midpoint with promising preliminary data, po...

Biotech Labz Supply Expands Catalog with 11 Documented Research Peptides
Biotech Labz Supply Inc now offers 11 high-purity research peptides, including BPC-157 and Tesamorelin, all backed by batch-specific certificate of an...

OTCQB Venture Market Showcases Gold, Hydrogen, AI, and Biotech in Two-Day Virtual Conference
B2i Digital's OTCQB Virtual Investor Conference on August 5-6 will feature presentations from 19 venture companies spanning critical minerals, natural...

MindWave Innovations Launches NILA Token on Licensed U.S. Exchange Ahead of MindChain Launch
MindWave Innovations' NILA token becomes available on a licensed U.S. exchange, marking a key step toward its October 2026 MindChain blockchain launch...

Oncotelic Therapeutics to Present at OTCQB Virtual Investor Conference, Highlighting Key Clinical and Platform Advancements
Oncotelic Therapeutics is set to present at the OTCQB Virtual Investor Conference, showcasing progress in its Phase 1b trial, platform validation, and...

Tonix Pharmaceuticals Receives FDA Feedback Supporting Phase 2 Study of Lyme Disease Prevention Candidate
Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 field study of TNX-4800, a long-acting monoclonal antibody for Lyme disea...

NextPlat Corp to Announce Q2 2026 Financial Results and Host Conference Call
NextPlat Corp will release its second quarter 2026 financial results on August 13, 2026, and host a conference call to discuss the outcomes and recent...

American Fusion Appoints Dr. Noah D’Amico as Strategic Advisor to Bolster Texatron Fusion Engine Testing
American Fusion Inc. strengthens its scientific team with Dr. Noah D’Amico’s appointment, advancing its fusion energy platform toward commercial deplo...

Helus Pharma Appoints Michael Halstead as CEO Amid Phase 3 Progress
Helus Pharma's appointment of Michael Halstead as CEO signals strategic leadership as the company advances its lead candidate HLP003 through Phase 3 t...

Independent Research Supports Broader Filovirus Vaccine Strategies, Highlighting Value of GeoVax's MVA Platform
Recent independent findings suggest cross-reactive immune responses among ebolaviruses, reinforcing the strategic importance of GeoVax's multi-antigen...

LataMed AI Partners with Droguerias Lala to Develop AI Tools for Pharmaceutical and Laboratory Workflows
LataMed AI Corp. has entered an agreement with Droguerias Lala C.A. to co-develop AI and automation software for pharmaceutical and laboratory operati...

NeuroOne to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call
NeuroOne Medical Technologies will release its Q3 FY2026 financial results on August 13, 2026, and hold a call to discuss performance and strategic up...

